JL
Therapeutic Areas
Risen Pharma Tech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RP903 | PROS (PIK3CA-Related Overgrowth Spectrum) | Clinical (pediatric trials) |
| ANGPTL3 siRNA | Undisclosed metabolic/cardiovascular | Phase 1 |
| KRAS inhibitor | Oncology | Preclinical/Phase 1 |
| Osteoarthritis program | Osteoarthritis | Clinical (China & US) |
| Alzheimer's program | Alzheimer's Disease | Clinical (China & US) |